Geoffroy Andrieux
- Oncology top 10%
- Cancer Cells and Metastasis 6
- CAR-T cell therapy research 6
- Cancer Research top 10%
-
- CRISPR and Genetic Engineering 10
- Epigenetics and DNA Methylation 6
- Pluripotent Stem Cells Research 5
-
- Immune Cell Function and Interaction 10
-
- Acute Myeloid Leukemia Research 8
-
- Genetic factors in colorectal cancer 6
- Co-authors
- Melanie BoerriesToni CathomenSajib ChakrabortyTatjana I. CornuJulia KlermundGiandomenico TurchianoMusaddeque AhmedClaudio Mussolino
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Nature Communications (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Geoffroy Andrieux
59 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 112
- Business and International Management 28
- Oncology 354
- Cancer Research 184
- Aging 17
- Molecular Biology 665
Countries citing papers authored by Geoffroy Andrieux
This map shows the geographic impact of Geoffroy Andrieux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffroy Andrieux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffroy Andrieux more than expected).
Fields of papers citing papers by Geoffroy Andrieux
This network shows the impact of papers produced by Geoffroy Andrieux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffroy Andrieux. The network helps show where Geoffroy Andrieux may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Geoffroy Andrieux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 42 | |
| 12 | 2023 | 11 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 59 | |
| 17 | 2020 | 4 | |
| 18 | 2020 | 22 | |
| 19 | 2019 | 17 | |
| 20 | 2018 | 73 |
About Geoffroy Andrieux
Geoffroy Andrieux is a scholar working on Hematology, Immunology and Cancer Research, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (10 papers), Immune Cell Function and Interaction (10 papers), Acute Myeloid Leukemia Research (8 papers), Cancer Cells and Metastasis (6 papers), CAR-T cell therapy research (6 papers), Epigenetics and DNA Methylation (6 papers), Genetic factors in colorectal cancer (6 papers) and Pluripotent Stem Cells Research (5 papers). The work is most often cited by research in Business and International Management (28 citations), Oncology (354 citations) and Cancer Research (184 citations). Geoffroy Andrieux has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Melanie Boerries, Toni Cathomen, Sajib Chakraborty, Tatjana I. Cornu, Julia Klermund, Giandomenico Turchiano, Musaddeque Ahmed, Claudio Mussolino, Gianni Monaco and Lucas Kook. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.